109 related articles for article (PubMed ID: 781981)
1. Prolonged survival of canine liver allografts perfused with antilymphocyte globulin (ALG).
Toledo-Pereyra LH; Condie RM; Callender CO; Sharp H; Buselmeier TJ; Simmons RL; Najarian JS
Trans Am Soc Artif Intern Organs; 1976; 22():211-5. PubMed ID: 781981
[No Abstract] [Full Text] [Related]
2. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
Toledo-Pereyra LH; Condie RM
J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
[TBL] [Abstract][Full Text] [Related]
3. Lung transplantation: improved survival of canine lung allografts perfused with antithymocyte globulin (ATG).
Toledo-Pereyra LH; Condie RM; Hau T; Simmons RL; Najarian JS
Bol Asoc Med P R; 1976 Sep; 68(9):234-8. PubMed ID: 802385
[No Abstract] [Full Text] [Related]
4. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
[No Abstract] [Full Text] [Related]
5. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
[No Abstract] [Full Text] [Related]
6. Prolongation of canine renal allografts: plasma or liver instead of blood transfusions combined with preoperative nonspecific immunosuppression.
Harder F; Floersheim GL; Jeekel J; van den Linden C; Mihatsch J; Rüedi T; Tondelli P
Transplant Proc; 1979 Mar; 11(1):978-81. PubMed ID: 377734
[No Abstract] [Full Text] [Related]
7. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
Caridis DT; Liegeois A; Barrett I; Monaco AP
Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
[No Abstract] [Full Text] [Related]
8. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
Toledo-Pereyra LH; Gordon DA; MacKenzie GH
Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of kidney allografts perfused by antilymphocyte globulin in vitro.
Callender CO; Simmons RL; Toledo-Pereyra LH; Santiago-Delpin EA; Najarian JS
Transplantation; 1973 Oct; 16(4):377-8. PubMed ID: 4583152
[No Abstract] [Full Text] [Related]
10. Extended survival of purified canine islet allografts with heterologous antilymphocyte globulin.
Kaufman DB; Morel P; Field MJ; Roney M; Condie R; Sutherland DE
Transplant Proc; 1991 Feb; 23(1 Pt 1):761-3. PubMed ID: 1990682
[No Abstract] [Full Text] [Related]
11. Antilymphoblast globulin (ALG) as initial prophylaxis against rejection following liver transplantation.
Greig PD; Levy G; Superina RA; Strasberg SM; Taylor BR; Blendis LM; Cameron R; Phillips MJ; Langer B
Transplant Proc; 1989 Feb; 21(1 Pt 2):2244-6. PubMed ID: 2652728
[No Abstract] [Full Text] [Related]
12. Mitigation of hyperacute rejection by antilymphocyte globulin (ALG).
Hammer C; Krebs G; Chaussy C; Pfeifer K; Schmidt K; Land W; Brendel W
Transplant Proc; 1979 Mar; 11(1):31-5. PubMed ID: 377651
[TBL] [Abstract][Full Text] [Related]
13. [Orthotopic transplantation of the liver in dogs (50 cases). Trial use of antilymphocyte serum].
Moreaux J; Huguet C; Hugier M; Martin E; Bloch P
Nouv Presse Med; 1972 Jan; 1(5):338. PubMed ID: 4551595
[No Abstract] [Full Text] [Related]
14. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
15. The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
Winearls CG; Fabre JW; Millard PR; Morris PJ
Clin Exp Immunol; 1979 Feb; 35(2):242-9. PubMed ID: 373937
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression with cyclophosphamide in dogs following cardiac transplantation.
Caves PK; Dong E; Shumway NE
Transplant Proc; 1973 Mar; 5(1):517-21. PubMed ID: 4121177
[No Abstract] [Full Text] [Related]
17. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
Collste LG
Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004
[No Abstract] [Full Text] [Related]
18. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
[No Abstract] [Full Text] [Related]
19. Immunological protection of rabbit corneal allografts. Survival of corneas pretreated with succinylated antilymphocyte globulin.
Chandler JW; Gebbhardt BM; Sugar J; Kaufman HE
Transplantation; 1974 Jan; 17(1):146-8. PubMed ID: 4588153
[No Abstract] [Full Text] [Related]
20. Mechanism for prolonged survival of pig renal allografts.
Perper RJ; Bowersox BE; Van Gorder TJ
Transplantation; 1971 Jun; 11(6):505-13. PubMed ID: 4931451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
